Status:
RECRUITING
Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.
Lead Sponsor:
KU Leuven
Conditions:
Hyaluronan-EnRiched Medium
Randomized Controlled Trial
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate
Eligibility Criteria
Inclusion
- Patients with own oocytes/embryos;
- Patients with female age at 1st OR in the study \<40 year;
- Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval
- Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals
- Patients with female age at 1st OR in the study \<40 year;
- Patients with BMI ≤32;
- Patients with written informed consent;
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04697823
Start Date
January 1 2021
End Date
December 31 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leuven University Fertility Center
Leuven, Belgium, 3000